Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are ...
Founded in Israel in 1998, the $600 million company's products are marketed to global consumer companies in 30 countries. Besides their core products, Enzymotec also maintains a strong clinical trial ...
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are ...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than ...
At close: June 28 at 6:07:38 p.m. EDT ...
Julian Robertson‘s Tiger Management has reported a large reduction in its holding of Enzymotec Ltd (NASDAQ:ENZY) in an amended filing with the Securities and Exchange Commission. Whereas the fund held ...
At close: 28 June at 6:07 pm GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results